Q: Is There A Generational Opportunity In Biotech Stocks?
Biotech 2026 = Tech 2023?
Biotech
Regeneron (REGN) – Q3 2025 Review
Eyeing A Breakout?
Novo Nordisk (NVO) - Q3 FY12/25 Earnings Review
Definitely Some Hair On This One
Initiating Coverage Of Merck & Co (MRK).
More evidence of rotation into healthcare stocks
ADMA Biologics Q2 FY12/25 Earnings Review
Running With The Big Dogs
BioNTech (BNTX): More Than a One Hit Wonder?
Another 90% Club Member
mRNA Strikes Back: Moderna’s Attempt at a Sequel (MRNA Q3 FY12/2025 Earnings Review)
Our Biotech Coverage Expands.
Invivyd - Company Review
$IVVD, A Speculative Play In Monoclonal Antibodies